Showing results (61-70 of 146) with videos related to
Sort By:
Pageof 15
Oncotarget|October 10, 2015
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.Immunobiology|November 9, 2015
IL12RB2 Polymorphisms correlate with risk of lung adenocarcinomaIgnazia Prigione, Angela Elvira Covone, Francesca Giacopelli, et al.Cell Death & Disease|October 14, 2023
Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttlingIlaria Petraroia, Patrizia Ghidotti, Giulia Bertolini, et al.Journal of Immunological Methods|November 29, 2021
Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjectsAlessandro Manenti, Elena Gianchecchi, Francesca Dapporto, et al.Tumori|September 17, 2022
Establishment of 6 pediatric rhabdomyosarcoma patient's derived xenograft models closely recapitulating patients' tumor characteristicsPatrizia Gasparini, Michela Casanova, Giovanni Centonze, et al.Annals of Surgical Oncology|January 5, 2019
Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung MetastasectomyUgo Pastorino, Daniele Morelli, Giovanni Leuzzi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2017
Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung CancersCarla Verri, Cristina Borzi, Todd Holscher, et al.International Journal of Molecular Sciences|November 17, 2019
The Landscape of Actionable Gene Fusions in Colorectal CancerFilippo Pagani, Giovanni Randon, Vincenzo Guarini, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2019
Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer modelsMassimo Moro, Daniela Di Paolo, Massimo Milione, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2003
Quantification of free circulating DNA as a diagnostic marker in lung cancerGabriella Sozzi, Davide Conte, MariaElena Leon, et al.Pageof 15